RE: outsourcing PK/PD analysis - help wanted
Hi Pawel, to add to the roll call I assume you know that Pharsight has a long
and established Consulting business in addition to it's Software division.
http://www.pharsight.com/services/index.php
There are some examples on the link above as well as some recorded webinars
which may be freely viewed;
http://www.pharsight.com/events/eventsonline_archive.php
Best regards and a Happy New Year to all,
Simon.
___________________________________
[email protected]
Senior Scientific Consultant
Pharsight- A Certara(tm) Company
Mobile : +44 7980 832 666
Facsimile : +1 801 991 7145
Home Office : +44 113 274 1198
Get tips and discuss Pharsight products with other
http://www.pharsight.com/extranet
___________________________________
Forthcoming meetings and training - http://www.pharsight.com/training;
Introduction to Phoenix v6.1: 8-10 Dec 2010, Paris, France.
Introduction to Phoenix v6.x: 22-24 Feb 2011 Berlin, Germany.
Introduction to Phoenix v6.x: 15-17 Mar 2011 Paris, France
Introduction to Phoenix v6.x: 12-14 Apr 2011 London, UK
Introduction to Phoenix v6.x: 10-12 May 2011 Amsterdam, NL.
Population analysis with Phoenix v6.1 NLME : 17-19 May 2011, Paris, France.
Population analysis with Phoenix v6.1 NLME : 6-7 Jun 2011, Athens, Greece
(Before PAGE)
2-3 April 2011, Two-day Pre ACOP-meeting Workshop: Population Modelling with
Phoenix NLME and Connect.
http://www.go-acop.org/2011/population-modeling-phoenix-nlme-and-connect
IVIVC toolkit Phoenix v6.x: 12 September 2011 Amsterdam, NL.
P Consider the environment; please don't print this email unless you really
need to.
Quoted reply history
________________________________
From: [email protected] [mailto:[email protected]] On
Behalf Of Michael Fossler
Sent: Thursday, January 06, 2011 6:28 PM
To: [email protected]; [email protected]
Subject: RE: [NMusers] outsourcing PK/PD analysis - help wanted
As President of the American College of Clinical Pharmacology, I am pleased to
point out that the Journal of Clinical Pharmacology (our flagship publication)
has excellent advertiser rates, and would be pleased to host information about
any of these fine CRO's, which will be read by drug development scientists all
over the world. Please see the following link:
https://www.accp1.org/pdf/30881_JCP_Rate_Card_web.pdf
Happy New Year,
Mike Fossler
President, ACCP
From: [email protected] [mailto:[email protected]] On
Behalf Of Mark Sale - Next Level Solutions
Sent: Thursday, January 06, 2011 1:01 PM
To: Leonid Gibiansky
Cc: [email protected]; [email protected]
Subject: RE: [NMusers] outsourcing PK/PD analysis - help wanted
[cid:382471121@06012011-2977]
I feel obligated to put my name into this as well, although Leonid has alway
been right about everything, so I assume he is about this as well. ; ) (but we
do our analyses with solar power).
Mark
Mark Sale MD
President, Next Level Solutions, LLC
http://www.NextLevelSolns.com
919-846-9185
A carbon-neutral company
See our real time solar energy production at:
http://enlighten.enphaseenergy.com/public/systems/aSDz2458
-------- Original Message --------
Subject: Re: [NMusers] outsourcing PK/PD analysis - help wanted
From: Leonid Gibiansky
<[email protected]<mailto:[email protected]>>
Date: Thu, January 06, 2011 11:33 am
To: [email protected]<mailto:[email protected]>
Cc: [email protected]<mailto:[email protected]>
I am sure, ours is the best one around :)
http://www.quantpharm.com
--------------------------------------
Leonid Gibiansky, Ph.D.
President, QuantPharm LLC
web: http://www.quantpharm.com
e-mail: LGibiansky at http://quantpharm.com
tel: (301) 767 5566
On 1/6/2011 10:59 AM, [email protected]<mailto:[email protected]> wrote:
> Hello,
>
> We try to outsource population PK/PD analyses of phase 3 data. When we
> google it, we find very few companies. Are there any mature/good
> companies around, which have submission expirience and do not advertise
> themselves well enough?
>
> Thanks!
>
> Pavel
>
_________________________________________________________________